HCW Biologics Inc.
HCWBNASDAQHealthcare● Active
$1.45
$-0.18(-11.04%)
Market Cap$3024477
P/E Ratio—
52W High$7.35
52W Low$0.25
HCW Biologics Inc. (HCWB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HCWB · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.05M | $2.57M | $2.84M | $6.72M | $0.00M |
| Cost of Revenue | $0.04M | $1.61M | $2.28M | $4.14M | $0.00M |
| Gross Profit | $0.01M | $0.96M | $0.56M | $2.59M | $0.00M |
| Gross Margin %(computed) | 20.00% | 37.38% | 19.72% | 38.48% | — |
| Operating Expenses | |||||
| R&D Expenses | $5.44M | $6.39M | $7.68M | $9.34M | $8.17M |
| G&A Expenses | $7.70M | $21.95M | $13.08M | $7.99M | $4.98M |
| Total Operating Expenses | $11.27M | $30.44M | $26.28M | $17.67M | $13.37M |
| Operating Income | ($11.26M) | ($29.48M) | ($25.72M) | ($15.08M) | ($13.37M) |
| Operating Margin %(computed) | — | — | -904.96% | -224.32% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.51M |
| Interest Expense | $1.25M | $1.16M | $0.28M | $0.13M | $0.00M |
| Income Before Tax | ($7.96M) | ($30.02M) | ($24.99M) | ($14.90M) | ($12.86M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($7.96M) | ($30.02M) | ($24.99M) | ($14.90M) | ($12.86M) |
| Net Margin %(computed) | — | — | -879.52% | -221.67% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-10.63 | $-0.77 | $-0.70 | $-0.42 | $-0.36 |
| Wtd Avg Shares | 2.10M | 38.79M | 35.93M | 35.82M | 35.77M |
| EBITDA | ($5.67M) | ($27.68M) | ($23.58M) | ($14.06M) | ($12.32M) |
| EBITDA Margin %(computed) | — | — | -829.62% | -209.10% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more HCW Biologics Inc. data
About HCW Biologics Inc. (HCWB) Income Statement
HCW Biologics Inc. (HCWB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HCWB reported revenue of $0.00B, gross profit of $0.00B (gross margin 20.00%), and net income of ($0.01B) — a net profit margin of -14677.14%.
Frequently asked questions
HCWB · 4 questionsHCW Biologics Inc. (HCWB) reported revenue of $0.00B for 2025, down 97.9% year-over-year.
HCWB revenueHCWB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08